C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation

Tatsuya Ozawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Koichi Ichimura(Hiroshima City Asa Citizens Hospital)
Acta Neuropathologica Communications
March 8, 2021
10.1186/s40478-021-01135-4
Cited by 25

Related Papers

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
|Nature Genetics|2009|788
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors
|Acta Neuropathologica Communications|2018|148
The Neurofibromatosis Type 1 Gene Product Neurofibromin Enhances Cell Motility by Regulating Actin Filament Dynamics via the Rho-ROCK-LIMK2-Cofilin Pathway
|Journal of Biological Chemistry|2005|91
Epstein–Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient
|Journal of Neuro-Oncology|2007|22